{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:33:28Z","timestamp":1771918408186,"version":"3.50.1"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>PTTM is a rare but fatal disease, characterized by endothelial intimal proliferation and pulmonary hypertension due to micro-vascular remodeling. In view of the poor prognosis, new effective strategies are urgently required.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns and diagnosis:<\/jats:title>\n            <jats:p>A 51-year-old woman was admitted to hospital for acute progressive dyspnea and dry cough. Clinical tests revealed hypercoagulable state and signs of severe pulmonary hypertension, without evidence of pulmonary embolism on contrast-enhanced CT. CT showed interlobular septal thickening and diffuse ground-glass opacity. Lung perfusion scan indicated multiple segment defect. Further right heart catherization proved a significant increase in pulmonary vascular resistance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>A combination therapy of apatinib and selexipag was administered for treatment of PTTM. The conventional therapies of ventilation, anticoagulation and diuretic medicines were initiated after admission.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Symptoms of PTTM were ameliorated with a reduction in pulmonary artery pressure. The resolution of interlobular septal thickening and ground-glass opacity on CT constituted the clinical benefits from treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Patient with PTTM will benefit from the combination strategy of apatinib, a VEGF-receptor antagonist, and selexipag, an oral prostacyclin receptor agonist.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029412","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T15:08:09Z","timestamp":1662649689000},"page":"e29412","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Case report: apatinib plus selexipag as a novel therapy for pulmonary tumor thrombotic microangiopathy accompanied by pulmonary hypertension associated with gastric carcinoma"],"prefix":"10.1097","volume":"101","author":[{"given":"Guofeng","family":"Ma","sequence":"first","affiliation":[{"name":"Regional medical center for National institute of respiratory diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Xu","sequence":"additional","affiliation":[{"name":"Regional medical center for National institute of respiratory diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liang","sequence":"additional","affiliation":[{"name":"Regional medical center for National institute of respiratory diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3112-9571","authenticated-orcid":false,"given":"Li","family":"Xu","sequence":"additional","affiliation":[{"name":"Regional medical center for National institute of respiratory diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/1097-0142(19900801)66:3<587::AID-CNCR2820660330>3.0.CO;2-J","article-title":"Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension","volume":"66","author":"von Herbay","year":"1990","journal-title":"Cancer"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2169\/internalmedicine.52.9472","article-title":"Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases","volume":"52","author":"Uruga","year":"2013","journal-title":"Intern Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/MCP.0000000000000297","article-title":"Pulmonary tumour thrombotic microangiopathy.","volume":"22","author":"Price","year":"2016","journal-title":"Curr Opin Pulm Med"},{"key":"R4-20250504","first-page":"7","article-title":"A case of pulmonary tumour thrombotic microangiopathy","volume":"16","author":"McAnearney","year":"2015","journal-title":"Respir Med Case Rep"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"2045894019851000","DOI":"10.1177\/2045894019851000","article-title":"Pulmonary tumor thrombotic microangiopathy: a systematic review","volume":"9","author":"Godbole","year":"2019","journal-title":"Pulm Circ"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/2156-7514.161978","article-title":"Pulmonary tumor thrombotic microangiopathy: clinical, radiologic, and histologic correlation","volume":"5","author":"Godbole","year":"2015","journal-title":"J Clin Imaging Sci"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1200\/JCO.2006.09.0670","article-title":"Pulmonary tumor thrombotic microangiopathy","volume":"25","author":"Miyano","year":"2007","journal-title":"J Clin Oncol"},{"key":"R8-20250504","first-page":"1269","article-title":"Pulmonary tumor embolism: relationship between clinical manifestations and pathologic findings [in","volume":"31","author":"Tamura","year":"1993","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1746-1596-6-27","article-title":"Pulmonary tumor thrombotic microangiopathy induced by gastric carcinoma: morphometric and immunohistochemical analysis of six autopsy cases","volume":"6","author":"Okubo","year":"2011","journal-title":"Diagn Pathol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.prp.2010.05.002","article-title":"Pulmonary tumor thrombotic microangiopathy in patients with gastric carcinoma: an analysis of 6 autopsy cases and review of the literature","volume":"206","author":"Chinen","year":"2010","journal-title":"Pathol Res Pract"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1536\/ihj.17-249","article-title":"Pulmonary tumor thrombotic microangiopathy due to advanced gastric cancer with Virchow\u2019s node metastasis","volume":"59","author":"Sato","year":"2018","journal-title":"Int Heart J"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2169\/internalmedicine.56.7439","article-title":"Pulmonary tumor thrombotic microangiopathy caused by a parotid tumor: early antemortem diagnosis and long-term survival","volume":"56","author":"Toyonaga","year":"2017","journal-title":"Intern Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/1097-0142(197510)36:4<1473::AID-CNCR2820360440>3.0.CO;2-D","article-title":"Microscopic pulmonary tumor emboli associated with dyspnea","volume":"36","author":"Kane","year":"1975","journal-title":"Cancer"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"180065","DOI":"10.1183\/16000617.0065-2018","article-title":"Tumoral pulmonary hypertension","volume":"28","author":"Price","year":"2019","journal-title":"Eur Respir Rev"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1161\/01.ATV.16.11.1365","article-title":"Osteopontin expression in platelet-derived growth factor-stimulated vascular smooth muscle cells and carotid artery after balloon angioplasty","volume":"16","author":"Wang","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1440-1827.2009.02439.x","article-title":"Osteopontin expression in pulmonary tumor thrombotic microangiopathy caused by gastric carcinoma","volume":"59","author":"Takahashi","year":"2009","journal-title":"Pathol Int"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","article-title":"Mechanisms of angiogenesis","volume":"386","author":"Risau","year":"1997","journal-title":"Nature"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/2045893217728072","article-title":"Insights on pulmonary tumor thrombotic microangiopathy: a seven-patient case series","volume":"7","author":"Godbole","year":"2017","journal-title":"Pulm Circ"},{"key":"R19-20250504","first-page":"E107","article-title":"Pulmonary tumor thrombotic microangiopathy from metastatic epithelioid angiosarcoma","volume":"5","author":"Demirag","year":"2013","journal-title":"J Thorac Dis"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.arbres.2016.04.010","article-title":"Radiological diagnosis of pulmonary tumor thrombotic microangiopathy: a non-bronchial cause of \u00abtree-in-bud\u00bb pattern on computed tomography [in","volume":"52","author":"Gorospe Saras\u00faa","year":"2016","journal-title":"Arch Bronconeumol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.3748\/wjg.v25.i48.6949","article-title":"Pulmonary tumor thrombotic microangiopathy of hepatocellular carcinoma: a case report and review of literature","volume":"25","author":"Morita","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1536\/ihj.14-220","article-title":"Platelet-derived growth factor receptor-tyrosine kinase inhibitor, imatinib, is effective for treating pulmonary hypertension induced by pulmonary tumor thrombotic microangiopathy","volume":"56","author":"Minatsuki","year":"2015","journal-title":"Int Heart J"},{"issue":"1 Suppl","key":"R23-20250504","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","article-title":"Inflammation, growth factors, and pulmonary vascular remodeling","volume":"54","author":"Hassoun","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s12876-021-02009-8","article-title":"Pulmonary tumor thrombotic microangiopathy in occult early gastric cancer that was undetectable on upper endoscopy: a case report and review of similar cases","volume":"21","author":"Kawakami","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCULATIONAHA.112.000765","article-title":"Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study","volume":"127","author":"Hoeper","year":"2013","journal-title":"Circulation"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.ijcard.2006.11.162","article-title":"Fatal acute pulmonary hypertension caused by pulmonary tumour thrombotic microangiopathy","volume":"124","author":"Keenan","year":"2008","journal-title":"Int J Cardiol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1164\/rccm.200707-1037OC","article-title":"Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension","volume":"178","author":"Perros","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1536\/ihj.51.272","article-title":"Imatinib mesylate has the potential to exert its efficacy by down-regulating the plasma concentration of platelet-derived growth factor in patients with pulmonary arterial hypertension","volume":"51","author":"Hatano","year":"2010","journal-title":"Int Heart J"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1186\/s40064-016-3280-4","article-title":"Imatinib could be a new strategy for pulmonary hypertension caused by pulmonary tumor thrombotic microangiopathy in metastatic breast cancer","volume":"5","author":"Fukada","year":"2016","journal-title":"Springerplus"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"bcr2017221032","DOI":"10.1136\/bcr-2017-221032","article-title":"Imatinib dramatically alleviates pulmonary tumour thrombotic microangiopathy induced by gastric cancer","volume":"2017","author":"Kubota","year":"2017","journal-title":"BMJ Case Rep"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2169\/internalmedicine.53.2379","article-title":"Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy","volume":"53","author":"Higo","year":"2014","journal-title":"Intern Med"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.2169\/internalmedicine.51.7682","article-title":"Pulmonary tumor thrombotic microangiopathy diagnosed antemortem and treated with combination chemotherapy","volume":"51","author":"Kayatani","year":"2012","journal-title":"Intern Med"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"e12169","DOI":"10.1097\/MD.0000000000012169","article-title":"Possibility of venoarterial extracorporeal membranous oxygenator being a bridging therapy for hemodynamic deterioration of pulmonary tumor thrombotic microangiopathy prior to initiating chemotherapy: a case report","volume":"97","author":"Iwashita","year":"2018","journal-title":"Med"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/jpet.107.124248","article-title":"2-[4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide (NS-304), an orally available and long-acting prostacyclin receptor agonist prodrug","volume":"322","author":"Kuwano","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1016\/j.bmc.2007.08.010","article-title":"Structure-activity studies on diphenylpyrazine derivatives: a novel class of prostacyclin receptor agonists","volume":"15","author":"Asaki","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/17476348.2021.1866990","article-title":"Selexipag for the treatment of pulmonary arterial hypertension","volume":"15","author":"Genecand","year":"2021","journal-title":"Expert Rev Respir Med"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.5603\/KP.2015.0242","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"73","author":"Gali\u00e8","year":"2015","journal-title":"Kardiol Pol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1358\/dot.2015.51.4.2320599","article-title":"Apatinib: a promising oral antiangiogenic agent in the treatment of multiple solid tumors","volume":"51","author":"Scott","year":"2015","journal-title":"Drugs Today"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/07357907.2017.1364745","article-title":"Realizing the potential of vascular targeted therapy: the rationale for combining vascular disrupting agents and anti-angiogenic agents to treat cancer","volume":"35","author":"Siemann","year":"2017","journal-title":"Cancer Invest"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"a006502","DOI":"10.1101\/cshperspect.a006502","article-title":"Signal transduction by vascular endothelial growth factor receptors","volume":"2","author":"Koch","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"10797","DOI":"10.1021\/jm301085w","article-title":"Vascular endothelial growth factor (VEGF) receptors: drugs and new inhibitors","volume":"55","author":"Musumeci","year":"2012","journal-title":"J Med Chem"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1634\/theoncologist.11-7-753","article-title":"Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions","volume":"11","author":"Morabito","year":"2006","journal-title":"Oncol"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cellsig.2007.05.013","article-title":"Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition","volume":"19","author":"Holmes","year":"2007","journal-title":"Cell Signal"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/13543776.2017.1344215","article-title":"VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016)","volume":"27","author":"Peng","year":"2017","journal-title":"Expert Opin Ther Pat"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrclinonc.2016.53","article-title":"Targeted therapy: Apatinib \u2013 new third-line option for refractory gastric or GEJ cancer","volume":"13","author":"Aoyama","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00210-020-02018-6","article-title":"Apatinib regulates the growth of gastric cancer cells by modulating apoptosis and autophagy","volume":"394","author":"Liu","year":"2021","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029412","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:13:38Z","timestamp":1746332018000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":46,"journal-issue":{"issue":"28","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029412","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]}}}